Start for free
Start for free
VB

Ventura BioMed Investors

North America, Georgia, United States, Germany

Description

Ventura BioMed Investors invest in early-stage life science companies developing pioneering technologies and innovative therapies.

Investor Profile

Ventura BioMed Investors has made 7 investments, with 1 in the past 12 months and 14% as lead.

Stage Focus

  • Seed (57%)
  • Series A (29%)
  • Series Unknown (14%)

Country Focus

  • Germany (71%)
  • United States (14%)
  • Switzerland (14%)

Industry Focus

  • Biotechnology
  • Product Research
  • Health Care
  • Health Diagnostics
  • Life Science
  • Medical Device
  • Personal Health
  • Therapeutics
  • Software
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ventura BioMed Investors frequently co-invest with?

OC
Co-Investments: 1
RV
Remiges Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 1
HTGF | High-Tech Gruenderfonds
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 5
LifeCare Partners
LifeCare Partners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Brandenburg Kapital
Brandenburg Kapital
Europe, Brandenburg, Germany, Potsdam
Co-Investments: 1
Verve Ventures
Verve Ventures
Europe, Zug, Switzerland, Zug
Co-Investments: 2
European Innovation Council
European Innovation Council
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
coparion
coparion
Europe, Nordrhein-Westfalen, Germany, Cologne
Co-Investments: 1
adesso ventures
adesso ventures
Europe, Berlin, Germany, Berlin
Co-Investments: 1

What are some of recent deals done by Ventura BioMed Investors?

IRUBIS

München, Bayern, Germany

IRUBIS offers bioprocessing and infrared spectroscopy services.

BiotechnologyProduct Research
SeedAug 29, 2024
iQure Pharma

Wilmington, Delaware, United States

iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.

BiotechnologyPharmaceuticalTherapeutics
Series UnknownOct 11, 2023
Amount Raised: $1,200,000
Nia Health

Berlin, Berlin, Germany

Innovating Medical Technology

Health CareHealth DiagnosticsLife ScienceMedical DevicePersonal HealthSoftwareTherapeutics
SeedMay 15, 2023
Amount Raised: $3,805,725
Navignostics

Zürich, Zurich, Switzerland

Navignostics aims to identify the ideal treatment to each cancer patient’s disease.

BioinformaticsBiotechnologyHealth CareHealth DiagnosticsLife ScienceMedicalMedical DevicePersonal Health
SeedNov 9, 2022
Amount Raised: $7,624,780
IRUBIS

München, Bayern, Germany

IRUBIS offers bioprocessing and infrared spectroscopy services.

BiotechnologyProduct Research
SeedOct 7, 2022
Amount Raised: $2,726,940
Kupando

Schönefeld, Brandenburg, Germany

Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.

Biotechnology
Series ASep 26, 2022
Amount Raised: $12,506,073
Abalos Therapeutics

Essen, Nordrhein-Westfalen, Germany

Abalos Therapeutics is an Essen, Germany-based developer of novel immuno-virotherapies against cancer.

Biotechnology
Series AOct 14, 2021
Amount Raised: $35,930,240
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator